Stockreport

NeuroVive Pharmaceutical AB Year End Report January - December 2019

ABLIVA AB  (NEVPF) 
NASDAQ:AMEX Investor Relations: neurovive.com/investor
PDF STOCKHOLM, Feb. 19, 2020 /PRNewswire/ --Important events in 2019KL1333            NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study        [Read more]